{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:04:57Z","timestamp":1779807897895,"version":"3.53.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,3]]},"abstract":"<jats:p>Benzodiazepines (BZDs) are widely used in the treatment of psychiatric disorders, but their association with suicidal\/self-injurious behavior is conflicting. This study investigated the relationship between BZDs and suicidal and self-injurious behavior, by analyzing data from the FDA Adverse Event Reporting System. We analyzed FDA Adverse Event Reporting System data from January 2004 and March 2025, to analyze adverse events (AEs) associated with suicidal and self-injurious behavior in BZDs. Thirty-eight BZDs were initially identified via the WHO Anatomical Therapeutic Chemical Code System. After excluding 26 BZDs with insufficient psychiatric disorder-related AEs (&lt;50 reports), 12 (diazepam, chlordiazepoxide, oxazepam, potassium clorazepate, lorazepam, bromazepam, clobazam, alprazolam, flurazepam, triazolam, temazepam, and midazolam) were retained for disproportionality analysis using zolpidem as a control. Reporting odds ratios (RORs) were calculated, and subgroup analysis assessed risk variations by age and gender. Among 52,767 psychiatric disorders AEs, 9474 (17.95%) involved suicidal and self-injurious behaviors. Compared to zolpidem, diazepam (ROR\u2005=\u20051.38), chlordiazepoxide (ROR\u2005=\u20051.62), oxazepam (ROR\u2005=\u20052.14), lorazepam (ROR\u2005=\u20051.11), alprazolam (ROR\u2005=\u20051.64), flurazepam (ROR\u2005=\u20053.26) triazolam (ROR\u2005=\u20051.68), and temazepam (ROR\u2005=\u20051.72) showed significantly elevated risks, while clobazam (ROR\u2005=\u20050.46) and midazolam (ROR\u2005=\u20050.37) demonstrated protective effects. Subgroup analyses revealed higher risks in females using diazepam, oxazepam, lorazepam, alprazolam and temazepam. Adults &lt;65 years who used potassium clorazepate, lorazepam, clobazam, alprazolam, or triazolam faced a significantly higher suicide-related risk than those \u226565 years. Compared to zolpidem, BZDs demonstrate varied suicide-related risks, which necessitated personalized risk-benefit evaluations and increased monitoring for high-risk agents such as flurazepam and alprazolam.<\/jats:p>","DOI":"10.1097\/md.0000000000044797","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:08:37Z","timestamp":1759781317000},"page":"e44797","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["What does data on adverse reactions reveal about benzodiazepines and suicide-related risk?: A disproportionality analysis using FDA FAERS pharmacovigilance data"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7059-415X","authenticated-orcid":false,"given":"Weiling","family":"Guo","sequence":"first","affiliation":[{"name":"Medical Department, Guangzhou Chest Hospital, Guangzhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Guangzhou Chest Hospital, Guangzhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Yang","sequence":"additional","affiliation":[{"name":"Anesthesia Department, Guangzhou Chest Hospital, Guangzhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Nosocomial Infection, Guangzhou Chest Hospital, Guangzhou, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260526","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s40261-016-0397-8","article-title":"Benzodiazepine use, misuse, and harm at the population level in Canada: a comprehensive narrative review of data and developments since 1995.","volume":"36","author":"Murphy","year":"2016","journal-title":"Clin Drug Investig"},{"key":"R2-20260526","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jpsychires.2020.05.020","article-title":"Benzodiazepine misuse among adults receiving psychiatric treatment.","volume":"128","author":"McHugh","year":"2020","journal-title":"J Psychiatr Res"},{"key":"R3-20260526","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1186\/s12889-020-08984-z","article-title":"Trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs in the health region of Lleida from 2002 to 2015.","volume":"20","author":"Torres-Bondia","year":"2020","journal-title":"BMC Public Health"},{"key":"R4-20260526","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eurpsy.2011.11.003","article-title":"Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal.","volume":"28","author":"Dell\u2019Osso","year":"2013","journal-title":"Eur Psychiatry"},{"key":"R5-20260526","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pbb.2008.01.001","article-title":"Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.","volume":"90","author":"Licata","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"R6-20260526","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/neurolint13040059","article-title":"Benzodiazepines: uses, dangers, and clinical considerations.","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol Int"},{"key":"R7-20260526","doi-asserted-by":"crossref","first-page":"e0284389","DOI":"10.1371\/journal.pone.0284389","article-title":"Global trends in antidepressant, atypical antipsychotic, and benzodiazepine use: a cross-sectional analysis of 64 countries.","volume":"18","author":"Alabaku","year":"2023","journal-title":"PLoS One"},{"key":"R8-20260526","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/13634593211060770","article-title":"And they slept happily ever after: online interpretive repertoires on the use of benzodiazepines and z-drugs.","volume":"27","author":"Ceuterick","year":"2023","journal-title":"Health (London)"},{"key":"R9-20260526","first-page":"D1052","article-title":"Systematic review of the side effects of benzodiazepines.","volume":"161","author":"Seldenrijk","year":"2017","journal-title":"Ned Tijdschr Geneeskd"},{"key":"R10-20260526","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: a systematic review.","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"R11-20260526","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1002\/pcn5.168","article-title":"Suicide attempt during ramelteon addition to flunitrazepam: a case report.","volume":"3","author":"Terao","year":"2024","journal-title":"PCN Rep"},{"key":"R12-20260526","doi-asserted-by":"crossref","first-page":"115857","DOI":"10.1016\/j.psychres.2024.115857","article-title":"Risk of suicide attempts and intentional self-harm on alprazolam.","volume":"335","author":"Gibbons","year":"2024","journal-title":"Psychiatry Res"},{"key":"R13-20260526","first-page":"407","article-title":"Self-harm and suicide associated with benzodiazepine usage.","volume":"57","author":"Neale","year":"2007","journal-title":"Br J Gen Pract"},{"key":"R14-20260526","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/acps.13582","article-title":"Risk of suicide attempt and suicide associated with benzodiazepine: a nationwide case crossover study.","volume":"148","author":"Tournier","year":"2023","journal-title":"Acta Psychiatr Scand"},{"key":"R15-20260526","first-page":"17lr02171","article-title":"Benzodiazepines do not cause suicide or suicide attempts.","volume":"19","author":"Rothschild","year":"2017","journal-title":"Prim Care Companion CNS Disord"},{"key":"R16-20260526","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004714-200002000-00003","article-title":"Comparison of the frequency of behavioral disinhibition on alprazolam, clonazepam, or no benzodiazepine in hospitalized psychiatric patients.","volume":"20","author":"Rothschild","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"R17-20260526","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-2002-25027","article-title":"A case control study on psychopharmacotherapy before suicide committed by 61 psychiatric inpatients.","volume":"35","author":"Gaertner","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"R18-20260526","first-page":"e84318","article-title":"Suicidal ideation and suicide completion in benzodiazepine users: a systematic review of current evidence.","volume":"17","author":"Khan","year":"2025","journal-title":"Cureus"},{"key":"R19-20260526","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jdin.2022.08.010","article-title":"Examining worldwide postmarketing suicides from biologics used for psoriasis with a focus on brodalumab: a cross-sectional analysis using the Food and Drug Administration Adverse Event Reporting System (FAERS).","volume":"9","author":"Yeroushalmi","year":"2022","journal-title":"JAAD Int"},{"key":"R20-20260526","doi-asserted-by":"crossref","first-page":"1208456","DOI":"10.3389\/fphar.2023.1208456","article-title":"Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system.","volume":"14","author":"Wei","year":"2023","journal-title":"Front Pharmacol"},{"key":"R21-20260526","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40264-022-01269-x","article-title":"Deliberate self-poisoning: real-time characterization of suicidal habits and toxidromes in the food and drug administration adverse event reporting system.","volume":"46","author":"Fusaroli","year":"2023","journal-title":"Drug Saf"},{"key":"R22-20260526","doi-asserted-by":"crossref","first-page":"114777","DOI":"10.1016\/j.psychres.2022.114777","article-title":"Zolpidem use and risk of suicide: a systematic review and meta-analysis.","volume":"316","author":"Khan","year":"2022","journal-title":"Psychiatry Res"},{"key":"R23-20260526","first-page":"24927","article-title":"Zolpidem: efficacy and side effects for insomnia.","volume":"9","author":"Edinoff","year":"2021","journal-title":"Health Psychol Res"},{"key":"R24-20260526","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1038\/s41598-020-61694-9","article-title":"Temporal association between zolpidem medication and the risk of suicide: a 12-year population-based, retrospective cohort study.","volume":"10","author":"Cho","year":"2020","journal-title":"Sci Rep"},{"key":"R25-20260526","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1176\/appi.ajp.2019.19030267","article-title":"Reducing suicidal ideation through insomnia treatment (REST-IT): a randomized clinical trial.","volume":"176","author":"McCall","year":"2019","journal-title":"Am J Psychiatry"},{"key":"R26-20260526","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1017\/S1092852925000318","article-title":"A systematic review of anti-suicidal effects of sedative-hypnotics and cognitive behavioral therapy for insomnia.","volume":"30","author":"Valentino","year":"2025","journal-title":"CNS Spectr"},{"key":"R27-20260526","first-page":"221","article-title":"Designing clinical trials to assess the impact of pharmacological treatment for suicidal ideation\/behavior: issues and potential solutions.","volume":"37","author":"Yao","year":"2023","journal-title":"Pharmaceut Med"},{"key":"R28-20260526","doi-asserted-by":"crossref","first-page":"119487","DOI":"10.1016\/j.jad.2025.119487","article-title":"The efficacy of lithium in the treatment of suicidal ideation, behavior and suicide: an updated systematic review and meta-analysis of randomized controlled trials.","volume":"387","author":"Wang","year":"2025","journal-title":"J Affect Disord"},{"key":"R29-20260526","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3390\/ph18050742","article-title":"Anti-suicidal effects of lithium, ketamine, and clozapine\u2014a 10-year systematic review.","volume":"18","author":"Waszak","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"R30-20260526","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40261-023-01272-9","article-title":"Newer antiseizure medications and suicidality: analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database.","volume":"43","author":"Leppien","year":"2023","journal-title":"Clin Drug Investig"},{"key":"R32-20260526","first-page":"17lr02171a","article-title":"Prescribed benzodiazepines and suicide risk: a review of the literature.","volume":"19","author":"Dodds","year":"2017","journal-title":"Prim Care Companion CNS Disord"},{"key":"R33-20260526","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1186\/s12889-020-09250-y","article-title":"Epidemiologic assessment of benzodiazepine exposure among suicide deaths in Colorado, 2015\u20132017.","volume":"20","author":"Ghosh","year":"2020","journal-title":"BMC Public Health"},{"key":"R34-20260526","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.sleep.2023.08.016","article-title":"Associations between insomnia medications and risk of death by suicide.","volume":"111","author":"Lavigne","year":"2023","journal-title":"Sleep Med"},{"key":"R35-20260526","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jad.2021.12.055","article-title":"Ketamine vs midazolam: mood improvement reduces suicidal ideation in depression.","volume":"300","author":"Hochschild","year":"2022","journal-title":"J Affect Disord"},{"key":"R36-20260526","doi-asserted-by":"crossref","first-page":"nsae041","DOI":"10.1093\/scan\/nsae041","article-title":"Potential association between suicide risk, aggression, impulsivity, and the somatosensory system.","volume":"19","author":"Lee","year":"2024","journal-title":"Soc Cogn Affect Neurosci"},{"key":"R37-20260526","first-page":"862","article-title":"Benzodiazepines\u2014their role in aggression and why GPs should prescribe with caution.","volume":"40","author":"Jones","year":"2011","journal-title":"Aust Fam Physician"},{"key":"R38-20260526","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/0269881118754734","article-title":"Relative toxicity of benzodiazepines and hypnotics commonly used for self-poisoning: an epidemiological study of fatal toxicity and case fatality.","volume":"32","author":"Geulayov","year":"2018","journal-title":"J Psychopharmacol"},{"key":"R39-20260526","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.genhosppsych.2019.11.005","article-title":"Association between suicide death and concordance with benzodiazepine treatment guidelines for anxiety and sleep disorders.","volume":"62","author":"Boggs","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"key":"R40-20260526","doi-asserted-by":"crossref","first-page":"109046","DOI":"10.1016\/j.drugalcdep.2021.109046","article-title":"Concomitant opioid and benzodiazepine use and risk of suicide attempt and intentional self-harm: pharmacoepidemiologic study.","volume":"228","author":"Gibbons","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"R41-20260526","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.puhe.2024.07.015","article-title":"Deaths of despair-associated mortality rates globally: a 2000\u20132019 sex-specific disparities analysis.","volume":"236","author":"Shirzad","year":"2024","journal-title":"Public Health"},{"issue":"Suppl 2","key":"R42-20260526","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.4103\/0019-5545.161484","article-title":"Suicide in women.","volume":"57","author":"Vijayakumar","year":"2015","journal-title":"Indian J Psychiatry"},{"key":"R43-20260526","doi-asserted-by":"crossref","first-page":"101613","DOI":"10.1016\/j.xcrm.2024.101613","article-title":"Addressing the gender paradox: effective suicide prevention strategies for women.","volume":"5","author":"Qu","year":"2024","journal-title":"Cell Rep Med"},{"key":"R44-20260526","doi-asserted-by":"crossref","first-page":"E214","DOI":"10.1097\/PHH.0000000000001764","article-title":"Developing the blueprint for youth suicide prevention.","volume":"29","author":"Gorzkowski Hamilton","year":"2023","journal-title":"J Public Health Manag Pract"},{"key":"R45-20260526","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13034-024-00753-9","article-title":"Youth suicide crisis: identifying at-risk individuals and prevention strategies.","volume":"18","author":"Ajluni","year":"2024","journal-title":"Child Adolesc Psychiatry Ment Health"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044797","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T14:28:25Z","timestamp":1779805705000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":44,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044797","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"2025-05-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}